WebMar 31, 2024 · Xgeva (denosumab) is a monoclonal antibody that is used to prevent bone-related events by binding to a protein called RANKL on osteoclasts (the cells that break down bone), inhibiting their formation, function, and survival. ... Xgeva is an injection that is administered every four weeks to prevent bone fractures in people with certain types of ... WebThe most common serious side effect of XGEVA® was shortness of breath. In multiple myeloma patients receiving XGEVA®, the most common side effects were diarrhea, nausea, low red blood cells, low blood platelets and calcium levels, back pain, swelling of the lower legs or hands, upper respiratory tract infection, rash, and headache.
Xgeva: 7 things you should know - Drugs.com
WebFeb 1, 2024 · Prolia; Xgeva; Descriptions. Denosumab injection is used to treat osteoporosis (thinning of the bones) in women who have an increased risk for fractures … WebNov 14, 2024 · back pain. skin rash. nausea*. swelling of the arms, legs, hands, or feet*. More common side effects in people who received Xgeva to help prevent broken bones due to bone cancer with solid tumors ... tooting kitchen
HIGHLIGHTS OF PRESCRIBING INFORMATION XGEVA …
WebAug 28, 2024 · Xgeva (denosumab) is a prescription drug that’s given as an injection. It treats bone cancers and hypercalcemia, and helps prevent broken bones. Learn about … WebApr 11, 2024 · A total of 252 subjects were planned to be enrolled and randomly assigned to the test group or the bridging control group or bioequivalence control group in a 1:1:1 ratio. Subjects in three groups received a single abdominal subcutaneous injection of pre- or post-change CMAB807X or Xgeva® #Denosumab# 120 mg, respectively. WebXGEVA ®, also called denosumab, is prescribed for people with bone metastases from breast, prostate, and other solid tumors (cancer) and for people with multiple myeloma. … tooting jobs